Funding from Foundations/Private Sources
JHU's Corporate and Foundation Relations maintains a Web site listing upcoming grant competitions that are sponsored by foundations and other private sources: http://jhuresearch.jhu.edu/OCFR.htm. They are in addition to the limited-submission RFPs periodically announced by the Research Projects Administration. The opportunities are listed in order of deadline and provides links to each funder's application information. Contact Joan Wisner-Carlson (email@example.com) with any questions.
DEADLINE: Monday, January 4, 2010
Funding is available to support multidisciplinary
research in prostate cancer through the
New Ideas Encouraged!
The Coordinating Center and Biospecimen Resource Sites must submit a single application.
The proposed LCBRN must collect, process, annotate, store, and distribute human lung cancer biospecimens that support two or more of the Areas of Emphasis listed below:
Submission is a two-step process consisting of pre-application submission and application submission. Pre-applications are REQUIRED for all award mechanisms.
Complete details about this opportunity
may be found on the Congressionally Directed Medical Research Programs
website at http://cdmrp.army.mil/funding/lcrp.htm
Fiscal Year 2009 (FY09) congressional appropriations have provided $112 million to the Department of Defense DOD) Peer Reviewed Orthopaedic Research Program (PRORP). This program will support innovative, high-impact, clinically relevant research to advance treatment and rapid rehabilitation from musculoskeletal injuries sustained during military combat or combat-related activities.
The PRORP Clinical Consortium Award is being offered for the first time in FY09. The intent of the award is to fund clinical studies focused on improving the outcomes of severe musculoskeletal injuries commonly associated with military combat. The main objective of this Consortium Award is to address questions that need to be answered through large multi-site clinical trials with appropriate statistical power. The award is designed to combine the population of military orthopaedic trauma patients and the combat-relevant expertise of PRORP-specified military treatment facilities with the patient populations and research expertise of highly qualified civilian orthopaedic trauma departments at outstanding institutions. Clinical outcomes will require longitudinal evaluations of definitive care which should include surgical reconstruction, clinical rehabilitation, and return to optimal function. The expected end results are an established infrastructure for continuing clinical studies on combat-relevant musculoskeletal injuries, and products (information, guidelines, validated techniques, or devices) that result in changes to, or validation of, current clinical practice that lead to better outcomes for our injured warriors. Pre-applications are REQUIRED for all PRORP award mechanisms.
Pre-Application (Letter of Intent) Deadline:
December 23, 2009
A detailed description of the award mechanism can be found in the FY09 PRORP Program Announcement and Application Instructions & General Information documents, which are available from the Grants.gov website (http://www.grants.gov), the CDMRP website (http://cdmrp.army.mil/funding/prorp.htm) and the CDMRP eReceipt Website (https://cdmrp.org).
The Maryland Stem Cell Commission has issued three official Requests for Applications (RFAs) for funding through the Maryland Stem Cell Research Fund under the Maryland Stem Cell Research Act. The grants to be awarded under these three RFAs will fund basic and translational research with human stem cells of all types, as defined in the Stem Cell Act. The goals of this program are to broaden and advance knowledge of human stem cell biology that will be relevant for eventual development of clinical applications, and to enable, support and accelerate such clinical applications for prevention, diagnosis and treatment of human diseases and conditions.
A one-page Letter of Intent is required and must be submitted by Nov. 12, 2009. Applications for funding under these RFAs will be due Jan. 14, 2010.
The Commission will give the highest priority to scientifically meritorious applications that include collaboration between for-profit and not-for-profit organizations in the state.
The work funded under these RFAs must be conducted in Maryland. The scientists and clinicians conducting the work must be employed or retained by an eligible Maryland-based organization while doing so.
All applications must include an explanation of the translation potential, a plan of the proposed research as well as a bioethics section. All Principal Investigators funded under these RFAs will be required to present their interim and final research results at an annual in-state symposium and in annual reports to the Maryland Stem Cell Research Commission.
New cell lines initially developed with funding under these RFAs will be required to be shared with other qualified researchers.
For more details on each of these funding opportunities, click here: http://www.mscrf.org/content/fundingopps/index.cfm
Questions about these
RFAs may only be addressed via the following contact: mscrfinfo@MarylandTEDCO.org.